Longaeva Partners’s ADARx Pharmaceuticals ADRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$299K Buy
+15,000
New +$300K 0.01% 287

Other funds holding ADRX

Longaeva Partners's ADRX Position: Q3 2026 in Review

Longaeva Partners opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 15,000 shares worth $299K. The stake represents 0.01% of the portfolio and ranks #287 among its holdings.

62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.

  • Longaeva Partners held 15,000 shares of ADARx Pharmaceuticals worth $299K as of Q3 2026.
  • ADARx Pharmaceuticals was a new Longaeva Partners position in Q3 2026.
  • ADARx Pharmaceuticals made up 0.01% of Longaeva Partners's portfolio in Q3 2026, its #287 holding.
  • 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.

Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.